Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Enterobacteriaceae

ABSTRACT: Multicenter clinical and molecular epidemiological analysis of carbapenem-resistant Enterobacteriaceae in Japan

PROVIDER: PRJDB8311 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR178361_1.fastq.gz	Fastqsanger.gz
	DRR178361_2.fastq.gz	Fastqsanger.gz
	DRR178362_1.fastq.gz	Fastqsanger.gz
	DRR178362_2.fastq.gz	Fastqsanger.gz
	DRR178363_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 184

Similar Datasets

Enterobacteriaceae

Project description:Molecular epidemiology of carbapenem-resistant Enterobacteriaceae in Osaka, Japan

| PRJDB6565 | ENA

Enterobacteriaceae

Project description:Carbapenem-resistant Enterobacteriaceae in Bloodstream Infection

| PRJNA479772 | ENA

Molecular Epidemiology of Enterobacterales Resistant to Antibiotics of Last Resort in Pregnant Women in Labour at a Tertiary Hospital

Project description:This study aims to determine the epidemiology of Enterobacteriaceae resistant to antibiotics of last resort in pregnant women in labour at a tertiary hospital, Pretoria, South Africa. Rectal swabs shall be used to screen for colonisation with CRE and colistin-resistant Enterobacteriales in pregnant women during labour. Carbapenem and colistin-resistant Enterobacterales can cause the following infections: bacteraemia; nosocomial pneumonia; urinary tract infections, and intra-abdominal infections. Due to limited treatment options, infections caused by these multidrug-resistant organisms are associated with a mortality rate of 40-50%. Screening for colonisation of carbapenem-resistant Enterobacteriaceae (CRE) and colistin-resistant Enterobacteriaceae will help implement infection and prevention measures to limit the spread of these multidrug-resistant organisms.

2022-07-20 | GSE208573 | GEO

Enterobacteriaceae

Project description:Whole-genome sequencing of carbapenem-resistant Enterobacteriaceae

| PRJDB4867 | ENA

Discovery and AI-guided mechanistic elucidation of a novel Enterobacteriaceae-specific antibiotic

Project description:Current clinical antibiotics are largely broad-spectrum agents that promote intestinal dysbiosis and colonisation of Enterobacteriaceae, which are often drug-resistant. Indeed, dysbiosis creates an ideal niche for adherent-invasive Escherichia coli (AIEC) in patients with inflammatory bowel disease (IBD). There is an urgent and unmet need for novel narrow-spectrum and microbiome-sparing antibiotics. Here, we screened >10,000 molecules for antibacterial activity against AIEC and discovered enterololin, an antibacterial compound with targeted activity against Enterobacteriaceae species. Molecular substructure- and deep learning-guided mechanism of action investigations revealed that enterololin perturbs lipoprotein trafficking through a mechanism involving the LolCDE complex. Moreover, enterololin can suppress an AIEC infection in mouse models, while largely preserving the overall microbiome composition. This work highlights the utility of deep learning methods for predicting molecular interactions, thereby accelerating mechanism of action elucidation of novel molecules, and identifies a promising Enterobacteriaceae-specific antibacterial candidate for further development to treat challenging infections in IBD patients.

2025-08-27 | GSE300731 | GEO

Enterobacteriaceae

Project description:AMED CRE Consortium: Carbapenem-resistant Enterobacteriaceae in Vietnam

| PRJDB7517 | ENA

Enterobacteriaceae

Project description:AMED CRE Consortium: Carbapenem-resistant Enterobacteriaceae in Vietnam

| PRJDB6407 | ENA

Enterobacteriaceae

Project description:Global studies of Children Carbapenem-resistant Enterobacteriaceae in China

| PRJNA1071731 | ENA

Enterobacteriaceae

Project description:Whole genome sequencing of colistin-resistant Enterobacteriaceae isolated in Japan

| PRJDB8148 | ENA

Identification of β-lactamases produced by Enterobacteriaceae

Project description:The increasing spread of drug-resistant bacterial strains presents great challenges to clinical antibacterial treatment and public health, particularly with regard to β-lactamase-producing Enterobacteriaceae. A rapid and accurate detection method that can expedite precise clinical diagnosis and rational administration of antibiotics is urgently needed.

2022-06-08 | PXD028791 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data